Sex-specific trends in lung cancer incidence and survival: A population study of 40 118 cases

Thorax

Volumn 66, Issue 4, 2011, Pages 301-307

  Sagerup, Camilla M T ^a   Småstuen, Milada ^b   Johannesen, Tom B ^b   Helland, Åslaug ^a   Brustugun, Odd Terje ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CARCINOID; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SARCOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NORWAY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL TIME; TREND STUDY;

EID: 79953026659     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.151621     Document Type: Article

References (40)

1. American Cancer Society. Global Cancer Facts & Figures. Atlanta, GA: American Cancer Society, 2007.
2. Freedman ND, Leitzmann MF, Hollenbeck AR, et al. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 2008;9:649-56.
3. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13:1087-93.
4. Visbal AL, Williams BA, Nichols FC 3rd, et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-15; discussion 15.
5. Levi F, Franceschi S, La Vecchia C, et al. Lung carcinoma trends by histologic type in Vaud and Neuchatel, Switzerland, 1974-1994. Cancer 1997;79:906-14.
6. Bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 2002;23:1-25. (Pubitemid 34205605)
7. Hsu LH, Chu NM, Liu CC, et al. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor? Lung Cancer 2009;66:262-7.
8. Wakelee HA, Wang W, Schiller JH, et al. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol 2006;1:441-6. (Pubitemid 47181421)
9. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-8. (Pubitemid 34438899)
10. Ferguson MK, Wang J, Hoffman PC, et al. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg 2000;69:245-9; discussion 9-50.
11. Chang JW, Asamura H, Kawachi R, et al. Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon? J Thorac Cardiovasc Surg 2009;137:807-12.
12. Alexiou C, Onyeaka CV, Beggs D, et al. Do women live longer following lung resection for carcinoma? Eur J Cardiothorac Surg 2002;21:319-25.
13. Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
14. American Cancer Society. Manual of Tumor Nomenclature and Coding. New York, NY: American Cancer Society, 1968.
15. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology. 2nd edn. Geneva: World Health Organization, 1990.
16. Doll R, Payne P, Waterhouse J, eds. Cancer Incidence in Five Continents: A Technical Report. Berlin: Springer-Verlag (for UICC), 1966.
17. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-42.
18. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-9. (Pubitemid 41379403)
19. Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol 2008;3:819-31.
20. Bain C, Feskanich D, Speizer FE, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004;96:826-34. (Pubitemid 38807603)
21. Lund KE, Lund M, Bryhni A. [Tobacco consumption among men and women 1927-2007] (in Norwegian). Tidsskr Nor Laegeforen 2009;129:1871-4.
22. Holmberg L, Sandin F, Bray F, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010;65:436-41.
23. von Plessen C, Strand TE, Wentzel-Larsen T, et al. Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study. Thorax 2008;63:866-71.
24. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001;31:139-48. (Pubitemid 32107010)
25. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-96. (Pubitemid 41443406)
26. Sakurai H, Asamura H, Goya T, et al. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. J Thorac Oncol 2010;5:1594-601.
27. Nordquist LT, Simon GR, Cantor A, et al. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-51. (Pubitemid 39093415)
28. Tsao AS, Liu D, Lee JJ, et al. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006;106:2428-36. (Pubitemid 43787667)
29. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004;125:27-37. (Pubitemid 38114560)
30. Toyooka S, Takano T, Kosaka T, et al. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma. Cancer Sci 2008;99:303-8. (Pubitemid 351228484)
31. Janssen-Heijnen ML, Schipper RM, Klinkhamer PJ, et al. Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study. Ann Oncol 1998;9:543-7.
32. Osterlind K, Andersen PK. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986;46:4189-94. (Pubitemid 16075929)
33. Johnson BE, Steinberg SM, Phelps R, et al. Female patients with small cell lung cancer live longer than male patients. Am J Med 1988;85:194-6.
34. Chee KG, Nguyen DV, Brown M, et al. Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited. Arch Intern Med 2008;168:1541-9.
35. Morgensztern D, Goodgame B, Baggstrom MQ, et al. The effect of FDG-PET on the stage distribution of non-small cell lung cancer. J Thorac Oncol 2008;3:135-9. (Pubitemid 351323187)
36. Pirker R, Pereira JR, Szczesna A, et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 2009;373:1525-31.
37. Rostad H, Strand TE, Langmark FY, et al. [Lung cancer without metastases - are all patients with resectable tumor operated?] (in Norwegian). Tidsskr Nor Laegeforen 2008;128:920-3.
38. Foegle J, Hedelin G, Lebitasy MP, et al. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol 2007;2:466-74.
39. de Perrot M, Licker M, Bouchardy C, et al. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg 2000;119:21-6. (Pubitemid 30046309)
40. Mahmud SM, Reilly M, Comber H. Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer 2003;41:57-64. (Pubitemid 36765484)